CLINICAL_TRIALS ClinicalTrials.gov record update

The Maximum Tolerated Dose and Minimum Effective Dose of OROS® Oxybutynin Compared to Ditropan® (Immediate-release Oxybutynin) in the Treatment of Patients With Urge or Mixed Urinary Incontinence

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00269750
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:10.863165+00:00
Published At: 2011-05-19T00:00:00+00:00
Record Updated At: 2011-05-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Urge Incontinence"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-05-19"
protocolSection.identificationModule.nctId: "NCT00269750"
protocolSection.identificationModule.officialTitle: "The Maximum Tolerated Dose and Minimum Effective Dose of OROS\u00ae Oxybutynin Compared to Ditropan\u00ae (Immediate-release Oxybutynin) in the Treatment of Patients With Urge or Mixed Urinary Incontinence"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.